• Conditions and diseases

  • Blood and immune system •
  • Cancer •
  • Cardiovascular •
  • Central nervous system •
  • Digestive system •
  • Ear and nose •
  • Endocrine, nutritional and metabolic •
  • Eye •
  • Gynaecology, pregnancy and birth •
  • Infectious diseases •
  • Injuries, accidents and wounds •
  • Mental health and behavioural conditions •
  • Mouth and dental •
  • Musculoskeletal •
  • Respiratory •
  • Skin •
  • Urogenital

• Public health

  • Accidents and injuries •
  • Alcohol •
  • Behaviour change •
  • Cancer •
  • Cardiovascular disease •
  • Child health •
  • Child social care •
  • Chronic illness •
  • Diabetes •
  • Drugs •
  • Environmental health •
  • Infectious diseases •
  • Maternal health •
  • Mental health •
  • Non-communicable diseases •
  • Obesity and diet •
  • Occupational health •
  • Older people •
  • Physical activity •
  • Sexual health •
  • Smoking and tobacco •
  • Transport •
  • Vaccine preventable diseases •
  • Working with and involving communities

• Treatments, Procedures and Devices

  • Bones and joint surgery •
  • Cardiovascular surgery •
  • Cardiovascular system drug treatments •
  • Clinical devices •
  • Diagnostic imaging •
  • Diagnostic procedures •
  • Digestive tract and other abdominal organs surgery •
  • Drug treatments •
  • Endocrine system and breast surgery •
  • Eye surgery •
  • Nervous system surgery •
  • Radiotherapy •
  • Screening •
  • Surgical procedures •
  • Therapeutic procedures •
  • Tissue and organ donation •
  • Urogenital surgery

• Guidance by type

  • Clinical Guidelines •
  • Technology appraisals •
  • Public health guidance •
  • Diagnostics guidance •
  • Interventional procedures guidance •
  • Medical technologies guidance •
  • Cancer service guidance •
  • Quality standards

• Guidance by date

  • View the guidance by date published

About NICE guidance Close

Navigation

• About NICE

• Who we are
  • Structure of NICE
  • Board
  • Senior Management Team
  • Guidance Executive
  • Partners Council
  • Policies and procedures
  • About the HDA
    • HDA publications
    • Evidence Base
    • NPHL Thesaurus
• What we do
• How we work
• NICE website development
• Jobs
• Tenders
• Scientific advice
• Commissioning Outcomes Framework
• Quality and Outcomes Framework
• NICE International
• NHS Evidence

Getting Evidence into Practice to Reduce Health Inequalities: Context and Progress on HDA Implementation

Viv Speller, Mike Kelly: March 2003 - Version 3

The objectives of the HDA's Evidence into Practice activities are: to bring together evidence of effectiveness in improving the health of the public, drawn from syntheses of research with the practical knowledge of how such effectiveness might be implemented; to bring about changes in public health practice based on evidence, theory and practical knowledge and wisdom; to ensure the sustainability and viability of these changes; and to identify good practice and link it to the best available evidence. The rationale underlying these objectives is to find the most effective means of improving the population's health and supporting the targeting of such work to tackle health inequalities within that population.

Getting Evidence into Practice to Reduce Health Inequalities: Context and Progress on HDA Implementation (85.9Kb 30sec @ 28.8Kbps)

Adobe Acrobat reader required.

This page was last updated: 30 April 2009